A Study of ES104 in Patients With Metastatic Colorectal Cancer

NCT05167448 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

58

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG: ES104
DRUG: ES104
DRUG: ES104

Sponsor

Elpiscience (Suzhou) Biopharma, Ltd.